Great West Life Assurance CO Krystal Biotech, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 27,373 shares of KRYS stock, worth $5.52 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,373
Previous 3,128
775.1%
Holding current value
$5.52 Million
Previous $557,000
803.41%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$796 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$578 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$490 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$269 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$206 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.17B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...